Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEWTON: EG-1962 vs Nimodipine in Aneurysmal Subarachnoid Hemorrhage
NCT01893190Phase 2Completed
- Sponsor
- Edge Therapeutics
- Start
- Sep 2013
- Primary completion
- Jan 2016
- Modality
- Nanoparticles, Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of EG-1962 in aneurysmal subarachnoid hemorrhage (SAH), sponsored by Edge Therapeutics. Started Sep 2013; status: completed.
02
Drugs
EG-1962
03
Conditions
aneurysmal subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on NCT01893190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01893190.